Interferon-γ release assay: A simple method for detection of varicella-zoster virus-specific cell-mediated immunity

Journal of Immunological Methods

Volumn 351, Issue 1-2, 2009, Pages 71-74

  Otani, Naruhito ^a   Baba, Koichi ^b   Okuno, Toshiomi ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b Baba Pediatric Clinic   (Japan)

Author keywords

Cell mediated immunity; Interferon ; Varicella zoster virus

Indexed keywords

GAMMA INTERFERON; VARICELLA ZOSTER VACCINE;

ADULT; ARTICLE; BLOOD CULTURE; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HERPES ZOSTER; HUMAN; IMMUNOASSAY; PRIORITY JOURNAL; SCHOOL CHILD; VARICELLA ZOSTER VIRUS; VIRUS IMMUNITY;

ADULT; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BLOOD CELLS; CELLS, CULTURED; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; INFANT; INTERFERON-GAMMA; PLAQUE ASSAY; VIROLOGY;

HERPES ZOSTER; HUMAN HERPESVIRUS 3;

EID: 70350591840     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2009.09.010     Document Type: Article

References (16)

1. Arvin A.M., and Koropchak C.M. Immunoglobulins M and G to varicella-zoster virus measured by solid-phase radioimmunoassay: antibody responses to varicella and herpes zoster infections. J. Clin. Microbiol. 12 (1980) 367
2. Arvin A.M., Moffat F., and Redman R. Varicella-zoster virus: aspects of pathogenesis and host response to natural infection and varicella vaccine. Adv. Virus Res. 46 (1996) 263
3. Dinnes J., Deeks J., Kunst H., Gibson A., Cummins E., Waugh N., Drobniewski F., and Lalvani A. A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol. Assess. 11 (2007) 1
4. Gershon A.A., LaRussa P., and Steinberg S. The varicella vaccine. Clinical trials in immunocompromised individuals. Infect. Dis. Clin. North Am. 10 (1996) 583
5. Hata A., Asanuma H., Rinki M., Sharp M., Wong R.M., Blume K., and Arvin A.M. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N. Engl. J. Med. 347 (2002) 26
6. Levin M.J., Smith J.G., Kaufhold R.M., Barber D., Hayward A.R., Chan C.Y., Chan I.S., Li D.J., Wang W., Keller P.M., Shaw A., Silber J.L., Schlienger K., Chalikonda I., Vessey S.J., and Caulfield M.J. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J. Infect. Dis. 188 (2003) 1336
7. Levin M.J., Oxman M.N., Zang J.H., Johnson G.R., Stanley H., Hayward A.R., Caulfield M.J., Irwin M.R., Smith J.G., Clair J., Chan I.S., Williams H., Harbecke R., Marchese R., Straus S.E., Gershon A., and Weinberg A. Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. J. Infect. Dis. 197 (2008) 825
8. Meyers J.D., Flournoy N., and Thomas E.D. Cell-mediated immunity to varicella-zoster virus after allogeneic marrow transplant. J. Infect. Dis. 141 (1980) 479
9. Myers M.G. Viremia caused by varicella-zoster virus: association with malignant progressive varicella. J. Infect. Dis. 140 (1979) 229
10. Oxman M.N., Levin M.J., Johnson G.R., Schmader K.E., Straus S.E., Gelb L.D., Arbeit R.D., Simberkoff M.S., Gershon A.A., Davis L.E., Weinberg A., Boardman K.D., Williams H.M., Zhang J.H., Peduzzi P.N., Beisel C.E., Morrison V.A., Guatelli J.C., Brooks P.A., Kauffman C.A., Pachucki C.T., Neuzil K.M., Betts R.F., Wright P.F., Griffin M.R., Brunell P., Soto N.E., Marques A.R., Keay S.K., Goodman R.P., Cotton D.J., Gnann Jr. J.W., Loutit J., Holodniy M., Keitel W.A., Crawford G.E., Yeh S.S., Lobo Z., Toney J.F., Greenberg R.N., Keller P.M., Harbecke R., Hayward A.R., Irwin M.R., Kyriakides T.C., Chan C.Y., Chan I.S., Wang W.W., Annunziato P.W., Silber J.L., and Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N. Engl. J. Med. 352 (2005) 22712284
11. Sartori A.M. A review of the varicella vaccine in immunocompromised individuals. Int. J. Infect. Dis. 8 (2004) 259
12. Takahashi M., Asano Y., Kamiya H., Baba K., Ozaki T., Otsuka T., and Yamanishi K. Development of varicella vaccine. J. Infect. Dis. 197 Suppl 2 (2008) S41
13. Webster A., Grint P., Brenner M.K., Prentice H.G., and Griffiths P.D. Titration of IgG antibodies against varicella zoster virus before bone marrow transplantation is not predictive of future zoster. J. Med. Virol. 27 (1989) 117
14. Wilson A., Sharp M., Koropchak C.M., Ting S.F., and Arvin A.M. Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation. J. Infect. Dis. 165 (1992) 119
15. Zaia J.A., Levin M.J., Preblud S.R., Leszczynski J., Wright G.G., and Ellis R.J. Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to varicella. J. Infect. Dis. 147 (1983) 737
16. Zhang Y., Cosyns M., Levin M.J., and Hayward A.R. Cytokine production in varicella zoster virus-stimulated limiting dilution lymphocyte cultures. Clin. Exp. Immunol. 98 (1994) 128